Treb schreef op 27 oktober 2015 09:41:
strijd in de USA, wie gaat het 'winnen' en tegen welke kosten?
www.optum.com/thought-leadership/comp..."While this new law has clarified the authority of the FDA over certain compounded medications, it still does not address some serious concerns. Therefore, due to concerns about member safety, drug efficacy and exceptionally high costs, UnitedHealthcare and OptumRx have decided to exclude from coverage certain bulk chemicals most frequently utilized in compounding."
"Recently, UnitedHealthcare and OptumRx have found that the use of compounded medicines is increasing. For example, over a recent 12 month period between 2012 and 2013, we saw a 35 percent increase in the use of compounding.
"This growth stems in part from the increasing number of pharmacies engaged in compounding. According to a compounding industry source, some 2,500 U.S. pharmacies added compounding practices between 2009 and 2012, bringing the total to over 7,500.7 We are also seeing compound pharmacies marketing to physicians across the country – well beyond their traditional service areas."
"High Cost Compounds vs. FDA Approved Alternatives
One point cannot be stressed enough: in most instances there are safe, effective, lower-cost alternatives to compounded medications. Remember the general rule for compounding medicines noted above: an FDA-approved product should be used wherever possible.4 The exceptions to this rule were always meant to be just that – unusual; singular; driven by the unique medical needs of the patient:"
"Conclusion
We believe that taking action against inappropriate, excessive compounding aligns well with a strategy that seeks to provide benefits for medications based on sound clinical evidence while also helping customers better manage the cost of care."